Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Impact of sheath size and hemostasis time on radial artery patency after transradial coronary angiography and intervention in Japanese and non-Japanese patients: A substudy from RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT) randomized multicenter trial

A. Aminian, S. Saito, A. Takahashi, I. Bernat, RL. Jobe, T. Kajiya, IC. Gilchrist, Y. Louvard, F. Kiemeneij, N. van Royen, M. van Leeuwen, S. Yamazaki, T. Matsukage, JF. Iglesias, SV. Rao,

. 2018 ; 92 (5) : 844-851. [pub] 20180216

Jazyk angličtina Země Spojené státy americké

Typ dokumentu srovnávací studie, časopisecké články, multicentrická studie, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc19045547

BACKGROUND: During transradial (TR) access, it remains unclear whether differences in baseline patients characteristics and hemostasis care impact the rate of radial artery occlusion (RAO). We sought to compare the rate of RAO after TR access with the 6 French(Fr) Glidesheath Slender (GSS6Fr, Terumo, Japan) or a standard 5 Fr sheath in Japanese and non-Japanese patients. METHODS AND RESULTS: The Radial Artery Patency and Bleeding, Efficacy, Adverse evenT (RAP and BEAT) trial randomized 1,836 patients undergoing TR coronary angiography and/or interventions to receive the GSS6Fr or the standard 5 Fr Glidesheath (GS5Fr, Terumo, Japan). Out of this study population, 1,087 were Japanese patients and 751 non-Japanese patients. The overall incidence of RAO was significantly higher in Japanese patients (3.6% vs. 1.2%, P = 0.002). Use of GSS6Fr was associated with higher rates of RAO than GS5Fr in Japanese patients (5% vs. 2.2%, P = 0.02) and with similar RAO rates in non-Japanese patients (1.3 vs. 1.1%, P = 1). The mean hemostasis time was significantly longer in Japanese patients (378 ± 253 vs. 159 ± 136 min, P < 0.001) and more Japanese patients had a hemostasis time of more than 6 hr (16.2% vs. 4.9%, P < 0.0001). Longer hemostasis time was an independent predictor of RAO (OR per additional hour 1.070, 95% CI 1.008-1.136, P = 0.03). CONCLUSIONS: Use of GSS6Fr was associated with a higher rate of RAO than a standard 5 Fr sheath in Japanese patients but not in non-Japanese patients. Whether improvement in post-procedural care and reduced hemostasis time could impact the incidence of RAO in Japanese patients should be further assessed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045547
003      
CZ-PrNML
005      
20200113105035.0
007      
ta
008      
200109s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ccd.27526 $2 doi
035    __
$a (PubMed)29451949
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Aminian, Adel $u Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium.
245    10
$a Impact of sheath size and hemostasis time on radial artery patency after transradial coronary angiography and intervention in Japanese and non-Japanese patients: A substudy from RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT) randomized multicenter trial / $c A. Aminian, S. Saito, A. Takahashi, I. Bernat, RL. Jobe, T. Kajiya, IC. Gilchrist, Y. Louvard, F. Kiemeneij, N. van Royen, M. van Leeuwen, S. Yamazaki, T. Matsukage, JF. Iglesias, SV. Rao,
520    9_
$a BACKGROUND: During transradial (TR) access, it remains unclear whether differences in baseline patients characteristics and hemostasis care impact the rate of radial artery occlusion (RAO). We sought to compare the rate of RAO after TR access with the 6 French(Fr) Glidesheath Slender (GSS6Fr, Terumo, Japan) or a standard 5 Fr sheath in Japanese and non-Japanese patients. METHODS AND RESULTS: The Radial Artery Patency and Bleeding, Efficacy, Adverse evenT (RAP and BEAT) trial randomized 1,836 patients undergoing TR coronary angiography and/or interventions to receive the GSS6Fr or the standard 5 Fr Glidesheath (GS5Fr, Terumo, Japan). Out of this study population, 1,087 were Japanese patients and 751 non-Japanese patients. The overall incidence of RAO was significantly higher in Japanese patients (3.6% vs. 1.2%, P = 0.002). Use of GSS6Fr was associated with higher rates of RAO than GS5Fr in Japanese patients (5% vs. 2.2%, P = 0.02) and with similar RAO rates in non-Japanese patients (1.3 vs. 1.1%, P = 1). The mean hemostasis time was significantly longer in Japanese patients (378 ± 253 vs. 159 ± 136 min, P < 0.001) and more Japanese patients had a hemostasis time of more than 6 hr (16.2% vs. 4.9%, P < 0.0001). Longer hemostasis time was an independent predictor of RAO (OR per additional hour 1.070, 95% CI 1.008-1.136, P = 0.03). CONCLUSIONS: Use of GSS6Fr was associated with a higher rate of RAO than a standard 5 Fr sheath in Japanese patients but not in non-Japanese patients. Whether improvement in post-procedural care and reduced hemostasis time could impact the incidence of RAO in Japanese patients should be further assessed.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a arteriální okluzní nemoci $x diagnostické zobrazování $x etnologie $x patofyziologie $7 D001157
650    12
$a Asijci $7 D044466
650    12
$a srdeční katétry $7 D062906
650    _2
$a periferní katetrizace $x škodlivé účinky $x přístrojové vybavení $7 D002406
650    _2
$a koronární angiografie $x škodlivé účinky $x přístrojové vybavení $7 D017023
650    _2
$a nemoci koronárních tepen $x diagnostické zobrazování $x etnologie $x patofyziologie $x terapie $7 D003324
650    _2
$a design vybavení $7 D004867
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a krvácení $x etnologie $7 D006470
650    12
$a hemostáza $7 D006487
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a koronární angioplastika $x škodlivé účinky $x přístrojové vybavení $7 D062645
650    _2
$a prospektivní studie $7 D011446
650    _2
$a arteria radialis $x diagnostické zobrazování $x patofyziologie $7 D017534
650    _2
$a rizikové faktory $7 D012307
650    _2
$a jednoduchá slepá metoda $7 D016037
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    12
$a průchodnost cév $7 D014654
651    _2
$a Japonsko $x epidemiologie $7 D007564
651    _2
$a Spojené státy americké $x epidemiologie $7 D014481
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Saito, Shigeru $u Shonan Kamakura General Hospital, Kanagawa, Japan.
700    1_
$a Takahashi, Akihiko $u Sakurakai Takahashi Hospital, Kobe, Japan.
700    1_
$a Bernat, Ivo $u University Hospital and Faculty of Medicine Pilsen, Pilsen, Czech Republic.
700    1_
$a Jobe, Robert Lee $u UNC Rex Healthcare, Raleigh, North Carolina.
700    1_
$a Kajiya, Takashi $u Tenyoukai Central Hospital, Kagoshima, Japan.
700    1_
$a Gilchrist, Ian C $u Pennsylvania State University, Heart & Vascular Institute, Hershey, Pennsylvania.
700    1_
$a Louvard, Yves $u Institut Hospitalier Jacques Cartier, Massy, France.
700    1_
$a Kiemeneij, Ferdinand $u Tergooi Hospital, Blaricum, The Netherlands. MC Zuiderzee, Lelystad, The Netherlands.
700    1_
$a van Royen, Niels $u VU University Medical Center, Amsterdam, The Netherlands.
700    1_
$a van Leeuwen, Maarten $u VU University Medical Center, Amsterdam, The Netherlands. Isala Heart Center, Zwolle, The Netherlands.
700    1_
$a Yamazaki, Seiji $u Sapporo Higashi Tokushukai Hospital, Hokkaido, Japan.
700    1_
$a Matsukage, Takashi $u Tokai University School of Medicine, Isehara, Japan.
700    1_
$a Iglesias, Juan F $u Geneva University Hospital, Geneva, Switzerland.
700    1_
$a Rao, Sunil V $u The Duke Clinical Research Institute, Durham, North Carolina.
773    0_
$w MED00005333 $t Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions $x 1522-726X $g Roč. 92, č. 5 (2018), s. 844-851
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29451949 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113105407 $b ABA008
999    __
$a ok $b bmc $g 1483815 $s 1084220
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 92 $c 5 $d 844-851 $e 20180216 $i 1522-726X $m Catheterization and cardiovascular interventions $n Catheter Cardiovasc Interv $x MED00005333
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Možnosti archivace